Characterized as an autosomal disorder affecting voluntary muscle movement, spinal muscular atrophy demonstrates limited therapeutic scope. However, its rising incidences, more so in children and infants, often leading to fatality has augmented significant advancement in drug development endeavors, thus reflecting favorably on the growth of  ... Read more

The Spinal Muscular Atrophy Market is estimated to be valued at US$ 1813.48 Mn in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

The Spinal Muscular Atrophy (SMA) Market is fragmented due to the presence of several international and regional players. These players are adopting several strategies such as new product launches and ... Read more